Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02876315 · ClinicalTrials.gov registry record · NA
The Effect of Combinatorial Nutritional Supplementation on Immune Function in Healthy Older Adults
A NA study, sponsored by Oregon State University.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT02876315: Completed NA study, sponsored by Oregon State University.
NCT02876315 is a NA study that has completed, run by Oregon State University. The registered enrollment target is 42 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02876315, a NA study, has completed, sponsored by Oregon State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
Many older adults do not get enough zinc, vitamin C and vitamin D, and this can be related to decreased ability to fight infection. The purpose of this research study is to determine if taking a multivitamin/mineral supplement every day for 12 weeks will increase the ability of immune cells in blood to kill bacteria.
Primary Outcome
Determine the clearance of S. aureus by whole blood from individuals before and after treatment with Redoxon VI or placebo using a whole blood killing functional assay
Interventions
- DIETARY_SUPPLEMENT placebo
- DIETARY_SUPPLEMENT Redoxon VI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2016-12 |
| Est. Completion | 2019-12 |
| Phase | NA |
What the finished NCT02876315 record still lists
NCT02876315 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT02876315 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02876315 about?
NCT02876315 is a clinical study titled "The Effect of Combinatorial Nutritional Supplementation on Immune Function in Healthy Older Adults". Many older adults do not get enough zinc, vitamin C and vitamin D, and this can be related to decreased ability to fight infection. The purpose of this research study is to determine if taking a multivitamin/mineral supplement every day for 12 weeks will increase the ability of immune cells in blood...
What is the current status of trial NCT02876315?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2016-12. Estimated completion is 2019-12.
What interventions are being tested in trial NCT02876315?
The interventions under investigation include: placebo (DIETARY_SUPPLEMENT), Redoxon VI (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02876315?
This trial is sponsored by Oregon State University, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02876315's enrollment target sits among peer trials
42 1436th of 2000 higher than 555 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia